Menu Back to 12th-Annual-Forum-for-Qualified-Persons-in-Pharmacovigilance

Overview

This is the only QPPV Forum designed for QPPVs by QPPVs, now in its 12th year and still going strong. This Forum continues to identify key trends requiring QPPV awareness, input and oversight. This year’s objectives, as shown below, build on past successes and have been shaped by valuable feedback provided by participants of the past eleven meetings, plus many years of QPPV and Regulator interaction at this Forum.

Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement of key regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This 12th QPPV Forum continues this successful approach.

 

Featured

Want to learn more about 2018 European Forum for Qualified Person for Pharmacovigilance (QPPV)? You've come to the right site!

Exhibits

Learn more

Short Course or Primer

To keep you at the forefront.

  • Oct 09, 2018

    Introduction to the Role of QPPVs

    Learn more

  • Oct 09, 2018

    The PSMF: Where Are We Today and Where Do We Want to Go?

    Learn more

What you will learn

  • Hear the latest updates and hot topics relating to the role of the QPPV
  • Explore long term PV visions, future directions of the ‘PV world’ and potential impact on the role of QPPV
  • Network with colleagues and meet regulators
  • Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
  • Take away practical hints and tips
  • Better understand regulatory and inspectorate expectations of the QPPV
  • Identify the expanded expectations of the role in the context of the continually evolving regulatory framework
  • Examine current areas of real challenge

    • Program Committee

    • Elspeth McIntosh, MBA, RN
      Elspeth McIntosh, MBA, RN • Director
      Castle Pharmacovigilance Ltd, United Kingdom
    • Margaret Anne Walters
      Margaret Anne Walters • Deputy EU Qualified Person for Pharmacovigilance
      Merck, Sharp & Dohme Ltd, United Kingdom
    • Vicki Edwards, RPh
      Vicki Edwards, RPh • Vice President, Pharmacovigilance Excellence and International QPPV
      AbbVie, United Kingdom
    • Doris Irene Stenver, MD, MPA
      Doris Irene Stenver, MD, MPA • Independent Pharmacovigilance Adviser
      Unique Advice, Denmark
    • Brian Edwards, DrMed
      Brian Edwards, DrMed • Vice President
      International Society of Pharmacovigilance, United Kingdom
    • Michael Richardson, MD, FFPM, FRCP
      Michael Richardson, MD, FFPM, FRCP • Senior Vice President, WorldWide Patient Safety
      Bristol-Myers Squibb, United Kingdom
    • Winrich Rauschning, DrMed, MD, MBA
      Winrich Rauschning, DrMed, MD, MBA • QPPV
      Biolitec Pharma, Germany
    • Barbara De Bernardi, MD
      Barbara De Bernardi, MD • EUQPPV Vice President - Head of Global QPPV Office
      Pfizer S.r.l., Italy
    • Peter De Veene, MD
      Peter De Veene, MD • EU QPPV
      Incyte, Belgium
    • Angela Van Der Salm, PhD, MSc
      Angela Van Der Salm, PhD, MSc • Director PV, Managing partner
      DADA Consultancy B.V., Netherlands
    • Magnus Ysander, MD
      Magnus Ysander, MD • EU & UK QPPV & Head Pharmacovigilance Excellence
      AstraZeneca, Sweden
    Load More

    Digital Learning Catalog

    DIA Learning: eLearning Soultions
    Download